Chronic blockade of NO synthase paradoxically increases islet NO production and modulates islet hormone release.
Islet production of nitric oxide (NO) and CO in relation to islet hormone secretion was investigated in mice given the NO synthase (NOS) inhibitor N(G)-nitro-L-arginine methyl ester (L-NAME) in their drinking water. In these mice, the total islet NO production was paradoxically increased, reflecting induction of inducible NOS (iNOS) in background of reduced activity and immunoreactivity of constitutive NOS (cNOS). Unexpectedly, normal mice fasted for 24 h also displayed iNOS activity, which was further increased in L-NAME-drinking mice. Glucose-stimulated insulin secretion in vitro and in vivo was increased in fasted but unaffected in fed mice after L-NAME drinking. Glucagon secretion was increased in vitro. Control islets incubated with different NOS inhibitors at 20 mM glucose displayed increased insulin release and decreased cNOS activity. These NOS inhibitors potentiated glucose-stimulated insulin release also from islets of L-NAME-drinking mice. In contrast, glucagon release was suppressed. In islets from L-NAME-drinking mice, cyclic nucleotides were upregulated, and forskolin-stimulated hormone release, CO production, and heme oxygenase (HO)-2 expression increased. In conclusion, chronic NOS blockade evoked iNOS-derived NO production in pancreatic islets and elicited compensatory mechanisms against the inhibitory action of NO on glucose-stimulated insulin release by inducing upregulation of the islet cAMP and HO-CO systems.
Henningsson
R
R
Institute of Physiological Sciences, University of Lund, Lund, Sweden. Ragnar.Henningsson@farm.lu.se
Alm
P
P
Lindström
E
E
Lundquist
I
I
D000818:Animals; D001786:Blood Glucose / Q000032:analysis; D002118:Calcium / Q000502:physiology; D002147:Calmodulin / Q000502:physiology; D002248:Carbon Monoxide / Q000378:metabolism; D002531:Cerebellum / Q000378:metabolism; D004791:Enzyme Inhibitors / Q000494:pharmacology*; D005215:Fasting / Q000097:blood; D005260:Female; D005934:Glucagon / Q000097:blood / Q000378:metabolism*; D005947:Glucose / Q000494:pharmacology; D007191:Indazoles / Q000494:pharmacology; D007328:Insulin / Q000097:blood / Q000378:metabolism*; D000078790:Insulin Secretion; D007515:Islets of Langerhans / Q000378:metabolism*; D051379:Mice; D008815:Mice, Inbred Strains; D019331:NG-Nitroarginine Methyl Ester / Q000494:pharmacology*; D009569:Nitric Oxide / Q000096:biosynthesis*; D019001:Nitric Oxide Synthase / Q000037:antagonists & inhibitors*; D009712:Nucleotides, Cyclic / Q000378:metabolism; D012016:Reference Values; D013997:Time Factors
D001786:Blood Glucose; D002147:Calmodulin; D004791:Enzyme Inhibitors; D007191:Indazoles; D007328:Insulin; D009712:Nucleotides, Cyclic; D009569:Nitric Oxide; D002248:Carbon Monoxide; D005934:Glucagon; D019001:Nitric Oxide Synthase; D005947:Glucose; D002118:Calcium; C080122:7-nitroindazole; D019331:NG-Nitroarginine Methyl Ester